Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced and unlikely to make it to market for several ...
Stocks soared Wednesday as investors digested strong earnings reports from several large financial services companies and ...